Lec 18 Fever in the Immunocompromised Host Flashcards
dirtiest areas in our bodies
mouth and large intestine
cytotoxic agent that affects VEGF
bevacizumab
febrile neutropenia criteria
Fever of >38.30C OR sustained fever ≥ 380C for 1 hour or more
AND
Absolute neutrophil count
cytotoxic agent that affects EGFR
cetuximab
cytotoxic agent that affects CD33
gemtuzumab
cytotoxic agent that affects HER2
trastuzumab
Prevention for high-risk patients with expected durations of prolonged and profound neutropenia (Absolute Neutrophil Count
Fluoroquinolone Prophylaxis
Prevention for those undergoing allogenic stem cell transplant and For those undergoing remission-induction or salvage induction chemotherapy for acute leukemia
Anti-Candida Prophylaxis
Prevention for those undergoing extensive chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome
Posaconazole Prophylaxis
Prevention for herpes simplex virus (HSV)-positive patients undergoing allogenic stem cell transplant or leukemia induction therapy
Acyclovir Prophylaxis
leading cause of cell-mediated immunity suppression
HIV
Requires the least amount of immunosuppression among all transplant organs
kidney transplant
ps. pag nakarating ka na dito, pakyu ka
Requires the highest amount of immunosuppression among all transplant organs
heart and intestines
First-line immunosuppressants
Calcineurin Inhibitors and Anti-proliferative agents
Immunosuppression peaks during the first ____ months post-transplant
6
Used for autoimmune diseases such as inflammatory bowel disease, rheumatoid arthritis, and psoriasis.
TNF agonists
targets CD20 found in B cells
rituximab
Why does DM cause increased infection?
- hyperglycemia effects
- Breaks in cutaneous and mucosal barrier due to microvascular angiopathy
- Neuropathy which diminishes pain sensation
Immune changes as we get older
- Functional change in T cell subsets, with a decrease in IL-2 secretion
- Naive T cells have decreased ability to respond to new antigens
- Humoral immunity mildly affected
Which of these can cause impairments in antibody-mediated immunity? A. Multiple myeloma B. Chronic lymphocytic leukemia C. Splenectomy D. Rituximab treatment E. AOTA
E